Cargando…
Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-κB-mediated apoptosis via MyD88/TRIF signaling
Cerebrovascular injury is the most prevalent human cerebrovascular disease and frequently results in ischemic stroke. Simvastatin may be a potential therapeutic agent for the treatment of patients with cerebrovascular injury. The present study aimed to investigate the efficacy of and the potential m...
Autores principales: | Chen, Zhiying, Xiang, Yuanyuan, Bao, Bing, Wu, Xiangbin, Xia, Zhongbin, You, Jianyou, Nie, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102662/ https://www.ncbi.nlm.nih.gov/pubmed/30066928 http://dx.doi.org/10.3892/mmr.2018.9337 |
Ejemplares similares
-
MyD88 and TRIF mediate divergent inflammatory and regenerative responses to skeletal muscle ischemia
por: Sachdev, Ulka, et al.
Publicado: (2014) -
Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88
por: Sakai, Jiro, et al.
Publicado: (2017) -
MyD88 deficiency aggravates the severity of acute pancreatitis by promoting MyD88-independent TRIF pathway-mediated necrosis
por: Yang, Du-Jiang, et al.
Publicado: (2022) -
Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling
por: Piras, Vincent, et al.
Publicado: (2014) -
Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice
por: Heuss, Neal D, et al.
Publicado: (2014)